← Open Payments lookup

JAMES CHO: Open Payments

NPI 1376706754 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$35,156 in 277 payments from 22 companies in 2025. Trend: 2023 $50,386 · 2024 $26,346 · 2025 $35,156

Honoraria: $22,075Food & beverage: $6,062Speaker / faculty: $3,575Travel & lodging: $3,444
CompanyPaymentsAmount
Supernus Pharmaceuticals, Inc.58$26,668
ABBVIE INC.14$4,046
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)35$786
Alkermes, Inc.15$460
Axsome Therapeutics, Inc.20$438
Otsuka America Pharmaceutical, Inc.16$421
Corium, LLC25$403
Teva Pharmaceuticals USA, Inc.9$377
E.R. Squibb & Sons, L.L.C.13$318
Neurocrine BioSciences, Inc.19$264

Products named: Qelbree, VRAYLAR, CAPLYTA, REXULTI, Azstarys, Auvelity, ARISTADA, COBENFY.

Industry payments across MO — which companies pay providers there.